Jeff Perl

Home dialysis should be an option for all who need dialysis! Let's improve access to and outcomes of home dialysis and ''build'' a brighter future together! lodz @brickdesign Thx Emily @LEGO_Group @YorkdaleStyle

@WashUNephrology @NephroMaven Congratulations Marcos !!!

We are thrilled to congratulate Dr. Marcos Rothstein (@Nephromaven) on being named a 2026 Dean’s Impact Award recipient! His leadership and dedication to kidney care continue to inspire us. More: nephrology.wustl.edu/marcos-rothste…

Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD bit.ly/49qlTTE #OpenAccess @KevinYauMD @NivethikaJ @SNDixon @KristinKClemens @PD_Perls @AmitXGarg @DrRonWald

"Is less more" when it comes to peritoneal dialysis? Dr. Jeff Perl (@PD_Perls) presents his case for starting eligible patients on incremental PD at City Wide Renal Rounds.

Free to Be in Peritoneal Dialysis: Without Kt/V? bit.ly/49Wyf4t (OPEN ACCESS) @IMWendyYe @JoanneBargman @PD_Perls

@Nephrosage @NDTsocial @vinckcaro @hjanders_hans @ERAkidney Does PD ?

Hemodialysis removes protective metabolites and disrupts mitochondrial function More info: academic.oup.com/ndt/article-ab… @NDTsocial, @vinckcaro, @hjanders_hans, @ERAkidney

Excited to welcome Dr. Jeffrey Perl @PD_Perls (@UofT , @UnityHealthTO) on Tues 1/20/26 for a special lecture “#PeritonealDialysis: Where Are We Going? Where Have We Been?” Join us 12–1 p.m. in Chromalloy Conference Rm. Lunch provided. nephrology.wustl.edu/visiting-profe…

Las peritonitis es la causa de pérdida de la técnica de diálisis peritoneal en el ~20% de los casos, por lo que es crucial evitar esta infección. Aquí las 6 estrategias más importantes. @PD_Perls CJASN 2025 10.2215/CJN.0000000976

Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD bit.ly/49qlTTE #OpenAccess @KevinYauMD @NivethikaJ @SNDixon @KristinKClemens @PD_Perls @AmitXGarg @DrRonWald

In Japan: Urgent dialysis initiations occurred in 16,176 patients (20%) - analysis from 85,973 admissions from 2014 to 2021 in the Diagnosis Procedure Combination database @PD_Perls kireports.org/article/S2468-…

#PDExchange Podcast returns with hosts @dr_nikhilshah and @PD_Perls to discuss the @ISPD1 position paper on Teaching PD published in @PDI_Journal Paper - bit.ly/4rpVKKY Podcast Links - Spotify - bit.ly/3UbmFLj Apple - bit.ly/3WSA4d8

🛎️ Did you miss the @ispd_nac October journal club on the Association of Sex With All-Cause and Cause-Specific Peritoneal Dialysis Discontinuation⁉️ @UofT @PD_Perls Don't worry, we have you covered! 👉 youtube.com/watch?v=Mv5vOg…

Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD bit.ly/49qlTTE (OPEN ACCESS) @KevinYauMD @NivethikaJ @SNDixon @KristinKClemens @PD_Perls @AmitXGarg @DrRonWald

Felicidades @jmanriquees , M Fernanda Sloan y a todo el equipo por un magnífico update. Y sobretodo por hacernos sentir en familia y cuidar los detalles al extremo. Ha sido un honor!! 🫶🏻

@AJKDonline @Miki_blasco @Dr_Bqg @torra_roser @DePsequera Congratulations @torra_roser and team 🧬 🫘 🇪🇸 🧬 🫘 🇪🇸

2025 AJKD Editors' Choice Award winning article: Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study bit.ly/3WeEZ72 @Miki_Blasco @Dr_Bqg @torra_roser @DePsequera #VisualAbstract

@edgarvlermamd @dr_nikhilshah @PDI_Journal Thank you @edgarvlermamd !

Thank you @PD_Perls @dr_nikhilshah @PDI_Journal for these opportunities #KidneyWk

#KidneyWk events on Nov. 7 from 4:30 -6:00 PM CST: - Re-Exploring Peritoneal Dialysis as an AKI treatment option: bit.ly/pdaki - Decision-Making at Transitions Along the Dialysis Pathway: bit.ly/dmtadp @PD_Perls

And together we raised $1.9M+ for St. Michael’s Hospital research. Thank you! #winner_2" target="_blank" rel="nofollow noopener">angelsden.ca/#winner_2 @PD_Perls

@kljohansenmd Editorial by Lawrence Slapcoff and @PD_Perls: bit.ly/3JcADum (FREE)

@PD_Perls @PDI_Journal #VisualAbstract @edgarvlermamd